TLDR: Singapore’s Bioethics Advisory Committee (BAC) has issued a recommendation against the clinical research and application of heritable gene editing, citing unknown long-term effects and the need for thorough safety and efficacy validation. The committee’s report, released on October 23, highlights the ethical complexities of altering the genetic makeup of future generations. The broader discussion on bioethics also touched upon the ethical implications of artificial intelligence in healthcare.
Singapore’s Bioethics Advisory Committee (BAC) has taken a cautious stance on heritable gene editing, advising against its clinical research or application within the nation. The committee’s newly released report, dated October 23, underscores significant concerns regarding the unknown long-term effects and the imperative for comprehensive validation of the technology’s safety and efficacy before any widespread use.
Heritable gene editing, a highly controversial area of biotechnology, involves modifying a person’s DNA in a way that can be passed down to future generations. Proponents suggest its potential for conferring resistance to diseases, treating infertility, or preventing fatal inherited conditions. However, the technology also opens the door to potentially engineering babies with desired traits, such as higher intelligence, raising profound ethical questions about human enhancement and unforeseen societal impacts.
In contrast, non-heritable gene editing, which modifies cells in the body that cannot be passed down to offspring, is already utilized in research to understand disease mechanisms, cancer development, and for diagnostic and drug discovery tools. Clinically, it is employed to correct disease-causing mutations and is currently regulated in Singapore. Research involving gene editing in germline cells or embryos is also conducted to advance scientific understanding of human embryos, though without gestation.
The BAC’s recommendation comes amidst rapid advancements in biotechnology, including both gene editing and artificial intelligence (AI), which collectively present complex ethical challenges. Professor Kenneth Mak emphasized the necessity for careful data management and responsible governance to maintain public trust in these evolving fields.
Also Read:
- Singapore Advances AI Governance and Quantum Resilience with New Initiatives
- Global Leaders, Including Hinton and Branson, Demand Ban on Superintelligent AI Development
Notably, the Asian Bioethics Network (ABN) Conference addressed the ethical dimensions of AI in healthcare, featuring discussions on emerging concepts like digital psychological twins and the potential for bias in AI-driven scheduling systems. This highlights the interconnectedness of various advanced technologies and the shared ethical considerations they demand.
